IBDEI040 ; ; 12-JAN-2012
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JAN 12, 2012
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,5101,1,4,0)
 ;;=4^Breast Cancer Screening
 ;;^UTILITY(U,$J,358.3,5101,2)
 ;;=^317968
 ;;^UTILITY(U,$J,358.3,5102,0)
 ;;=616.0^^47^358^18
 ;;^UTILITY(U,$J,358.3,5102,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5102,1,3,0)
 ;;=3^616.0
 ;;^UTILITY(U,$J,358.3,5102,1,4,0)
 ;;=4^Cervicitis
 ;;^UTILITY(U,$J,358.3,5102,2)
 ;;=^21925
 ;;^UTILITY(U,$J,358.3,5103,0)
 ;;=078.10^^47^358^21
 ;;^UTILITY(U,$J,358.3,5103,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5103,1,3,0)
 ;;=3^078.10
 ;;^UTILITY(U,$J,358.3,5103,1,4,0)
 ;;=4^Condyloma
 ;;^UTILITY(U,$J,358.3,5103,2)
 ;;=^295787
 ;;^UTILITY(U,$J,358.3,5104,0)
 ;;=625.3^^47^358^28
 ;;^UTILITY(U,$J,358.3,5104,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5104,1,3,0)
 ;;=3^625.3
 ;;^UTILITY(U,$J,358.3,5104,1,4,0)
 ;;=4^Dysmenorrhea
 ;;^UTILITY(U,$J,358.3,5104,2)
 ;;=^37592
 ;;^UTILITY(U,$J,358.3,5105,0)
 ;;=625.0^^47^358^29
 ;;^UTILITY(U,$J,358.3,5105,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5105,1,3,0)
 ;;=3^625.0
 ;;^UTILITY(U,$J,358.3,5105,1,4,0)
 ;;=4^Dyspareunia
 ;;^UTILITY(U,$J,358.3,5105,2)
 ;;=^37604
 ;;^UTILITY(U,$J,358.3,5106,0)
 ;;=788.1^^47^358^33
 ;;^UTILITY(U,$J,358.3,5106,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5106,1,3,0)
 ;;=3^788.1
 ;;^UTILITY(U,$J,358.3,5106,1,4,0)
 ;;=4^Dysuria
 ;;^UTILITY(U,$J,358.3,5106,2)
 ;;=^37716
 ;;^UTILITY(U,$J,358.3,5107,0)
 ;;=789.30^^47^358^64
 ;;^UTILITY(U,$J,358.3,5107,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5107,1,3,0)
 ;;=3^789.30
 ;;^UTILITY(U,$J,358.3,5107,1,4,0)
 ;;=4^Pelvic Abdominal Mass
 ;;^UTILITY(U,$J,358.3,5107,2)
 ;;=^917
 ;;^UTILITY(U,$J,358.3,5108,0)
 ;;=614.9^^47^358^65
 ;;^UTILITY(U,$J,358.3,5108,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5108,1,3,0)
 ;;=3^614.9
 ;;^UTILITY(U,$J,358.3,5108,1,4,0)
 ;;=4^Pelvic Inflammatory Disease
 ;;^UTILITY(U,$J,358.3,5108,2)
 ;;=^3537
 ;;^UTILITY(U,$J,358.3,5109,0)
 ;;=218.9^^47^358^87
 ;;^UTILITY(U,$J,358.3,5109,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5109,1,3,0)
 ;;=3^218.9
 ;;^UTILITY(U,$J,358.3,5109,1,4,0)
 ;;=4^Uterine Fibroids
 ;;^UTILITY(U,$J,358.3,5109,2)
 ;;=^68944
 ;;^UTILITY(U,$J,358.3,5110,0)
 ;;=618.1^^47^358^88
 ;;^UTILITY(U,$J,358.3,5110,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5110,1,3,0)
 ;;=3^618.1
 ;;^UTILITY(U,$J,358.3,5110,1,4,0)
 ;;=4^Uterine Prolapse
 ;;^UTILITY(U,$J,358.3,5110,2)
 ;;=^124773
 ;;^UTILITY(U,$J,358.3,5111,0)
 ;;=112.1^^47^358^90
 ;;^UTILITY(U,$J,358.3,5111,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5111,1,3,0)
 ;;=3^112.1
 ;;^UTILITY(U,$J,358.3,5111,1,4,0)
 ;;=4^Vaginitis, Candidal
 ;;^UTILITY(U,$J,358.3,5111,2)
 ;;=^18615
 ;;^UTILITY(U,$J,358.3,5112,0)
 ;;=099.53^^47^358^93
 ;;^UTILITY(U,$J,358.3,5112,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5112,1,3,0)
 ;;=3^099.53
 ;;^UTILITY(U,$J,358.3,5112,1,4,0)
 ;;=4^Vaginits, Chlamydial
 ;;^UTILITY(U,$J,358.3,5112,2)
 ;;=^293988
 ;;^UTILITY(U,$J,358.3,5113,0)
 ;;=131.01^^47^358^91
 ;;^UTILITY(U,$J,358.3,5113,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5113,1,3,0)
 ;;=3^131.01
 ;;^UTILITY(U,$J,358.3,5113,1,4,0)
 ;;=4^Vaginitis, Trichonomal
 ;;^UTILITY(U,$J,358.3,5113,2)
 ;;=^121763
 ;;^UTILITY(U,$J,358.3,5114,0)
 ;;=592.0^^47^358^51
 ;;^UTILITY(U,$J,358.3,5114,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5114,1,3,0)
 ;;=3^592.0
 ;;^UTILITY(U,$J,358.3,5114,1,4,0)
 ;;=4^Kidney Stones
 ;;^UTILITY(U,$J,358.3,5114,2)
 ;;=^67056
 ;;^UTILITY(U,$J,358.3,5115,0)
 ;;=627.2^^47^358^84
 ;;^UTILITY(U,$J,358.3,5115,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5115,1,3,0)
 ;;=3^627.2
 ;;^UTILITY(U,$J,358.3,5115,1,4,0)
 ;;=4^Symptomatic Menopause
 ;;^UTILITY(U,$J,358.3,5115,2)
 ;;=^328735
 ;;^UTILITY(U,$J,358.3,5116,0)
 ;;=622.10^^47^358^30
 ;;^UTILITY(U,$J,358.3,5116,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5116,1,3,0)
 ;;=3^622.10
 ;;^UTILITY(U,$J,358.3,5116,1,4,0)
 ;;=4^Dysplasia of Cervix
 ;;^UTILITY(U,$J,358.3,5116,2)
 ;;=^331546
 ;;^UTILITY(U,$J,358.3,5117,0)
 ;;=622.11^^47^358^31
 ;;^UTILITY(U,$J,358.3,5117,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5117,1,3,0)
 ;;=3^622.11
 ;;^UTILITY(U,$J,358.3,5117,1,4,0)
 ;;=4^Dysplasia of Cervix, Mild
 ;;^UTILITY(U,$J,358.3,5117,2)
 ;;=^331547
 ;;^UTILITY(U,$J,358.3,5118,0)
 ;;=622.12^^47^358^32
 ;;^UTILITY(U,$J,358.3,5118,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5118,1,3,0)
 ;;=3^622.12
 ;;^UTILITY(U,$J,358.3,5118,1,4,0)
 ;;=4^Dysplasia of Cervix, Moderate
 ;;^UTILITY(U,$J,358.3,5118,2)
 ;;=^331548
 ;;^UTILITY(U,$J,358.3,5119,0)
 ;;=V72.40^^47^358^71
 ;;^UTILITY(U,$J,358.3,5119,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5119,1,3,0)
 ;;=3^V72.40
 ;;^UTILITY(U,$J,358.3,5119,1,4,0)
 ;;=4^Pregnancy Exam/Test
 ;;^UTILITY(U,$J,358.3,5119,2)
 ;;=^331589
 ;;^UTILITY(U,$J,358.3,5120,0)
 ;;=V67.01^^47^358^63
 ;;^UTILITY(U,$J,358.3,5120,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5120,1,3,0)
 ;;=3^V67.01
 ;;^UTILITY(U,$J,358.3,5120,1,4,0)
 ;;=4^Pap Smear Following Surgery
 ;;^UTILITY(U,$J,358.3,5120,2)
 ;;=^322078
 ;;^UTILITY(U,$J,358.3,5121,0)
 ;;=627.4^^47^358^12
 ;;^UTILITY(U,$J,358.3,5121,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5121,1,3,0)
 ;;=3^627.4
 ;;^UTILITY(U,$J,358.3,5121,1,4,0)
 ;;=4^Artificial Menopause-Symptomatic
 ;;^UTILITY(U,$J,358.3,5121,2)
 ;;=^328736
 ;;^UTILITY(U,$J,358.3,5122,0)
 ;;=793.80^^47^358^3
 ;;^UTILITY(U,$J,358.3,5122,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5122,1,3,0)
 ;;=3^793.80
 ;;^UTILITY(U,$J,358.3,5122,1,4,0)
 ;;=4^Abnormal Mammogram
 ;;^UTILITY(U,$J,358.3,5122,2)
 ;;=^323613
 ;;^UTILITY(U,$J,358.3,5123,0)
 ;;=V76.47^^47^358^80
 ;;^UTILITY(U,$J,358.3,5123,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5123,1,3,0)
 ;;=3^V76.47
 ;;^UTILITY(U,$J,358.3,5123,1,4,0)
 ;;=4^Special Screening for vaginal Malignant Neoplasms
 ;;^UTILITY(U,$J,358.3,5123,2)
 ;;=^322085
 ;;^UTILITY(U,$J,358.3,5124,0)
 ;;=V45.77^^47^358^8
 ;;^UTILITY(U,$J,358.3,5124,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5124,1,3,0)
 ;;=3^V45.77
 ;;^UTILITY(U,$J,358.3,5124,1,4,0)
 ;;=4^Acquired Absence of Uterus
 ;;^UTILITY(U,$J,358.3,5124,2)
 ;;=^322067
 ;;^UTILITY(U,$J,358.3,5125,0)
 ;;=233.1^^47^358^16
 ;;^UTILITY(U,$J,358.3,5125,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5125,1,3,0)
 ;;=3^233.1
 ;;^UTILITY(U,$J,358.3,5125,1,4,0)
 ;;=4^CA in Situ (Sev. Dysplasia)
 ;;^UTILITY(U,$J,358.3,5125,2)
 ;;=^267736
 ;;^UTILITY(U,$J,358.3,5126,0)
 ;;=789.00^^47^358^1
 ;;^UTILITY(U,$J,358.3,5126,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5126,1,3,0)
 ;;=3^789.00
 ;;^UTILITY(U,$J,358.3,5126,1,4,0)
 ;;=4^Abdom Pain, Unsp Site
 ;;^UTILITY(U,$J,358.3,5126,2)
 ;;=^303317
 ;;^UTILITY(U,$J,358.3,5127,0)
 ;;=795.09^^47^358^2
 ;;^UTILITY(U,$J,358.3,5127,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5127,1,3,0)
 ;;=3^795.09
 ;;^UTILITY(U,$J,358.3,5127,1,4,0)
 ;;=4^Abn Pap Cervix HPV NEC
 ;;^UTILITY(U,$J,358.3,5127,2)
 ;;=^331974
 ;;^UTILITY(U,$J,358.3,5128,0)
 ;;=V45.77^^47^358^7
 ;;^UTILITY(U,$J,358.3,5128,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5128,1,3,0)
 ;;=3^V45.77
 ;;^UTILITY(U,$J,358.3,5128,1,4,0)
 ;;=4^Acq Absence Org,Genitals
 ;;^UTILITY(U,$J,358.3,5128,2)
 ;;=^322067
 ;;^UTILITY(U,$J,358.3,5129,0)
 ;;=215.9^^47^358^13
 ;;^UTILITY(U,$J,358.3,5129,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5129,1,3,0)
 ;;=3^215.9
 ;;^UTILITY(U,$J,358.3,5129,1,4,0)
 ;;=4^Ben Neo Soft Tissue NOS
 ;;^UTILITY(U,$J,358.3,5129,2)
 ;;=^267620
 ;;^UTILITY(U,$J,358.3,5130,0)
 ;;=221.2^^47^358^14
 ;;^UTILITY(U,$J,358.3,5130,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5130,1,3,0)
 ;;=3^221.2
 ;;^UTILITY(U,$J,358.3,5130,1,4,0)
 ;;=4^Benign Neoplasm Vulva
 ;;^UTILITY(U,$J,358.3,5130,2)
 ;;=^267650
 ;;^UTILITY(U,$J,358.3,5131,0)
 ;;=795.05^^47^358^17
 ;;^UTILITY(U,$J,358.3,5131,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5131,1,3,0)
 ;;=3^795.05
 ;;^UTILITY(U,$J,358.3,5131,1,4,0)
 ;;=4^Cervical (HPV) DNA POS
 ;;^UTILITY(U,$J,358.3,5131,2)
 ;;=^331573
 ;;^UTILITY(U,$J,358.3,5132,0)
 ;;=701.0^^47^358^20
 ;;^UTILITY(U,$J,358.3,5132,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5132,1,3,0)
 ;;=3^701.0
 ;;^UTILITY(U,$J,358.3,5132,1,4,0)
 ;;=4^Circumscribe Scleroderma
 ;;^UTILITY(U,$J,358.3,5132,2)
 ;;=^108577
 ;;^UTILITY(U,$J,358.3,5133,0)
 ;;=618.01^^47^358^26
 ;;^UTILITY(U,$J,358.3,5133,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5133,1,3,0)
 ;;=3^618.01
 ;;^UTILITY(U,$J,358.3,5133,1,4,0)
 ;;=4^Cystocele, Midline
 ;;^UTILITY(U,$J,358.3,5133,2)
 ;;=^331534
 ;;^UTILITY(U,$J,358.3,5134,0)
 ;;=621.30^^47^358^35
 ;;^UTILITY(U,$J,358.3,5134,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5134,1,3,0)
 ;;=3^621.30
 ;;^UTILITY(U,$J,358.3,5134,1,4,0)
 ;;=4^Endometrial Hyperplas NOS
 ;;^UTILITY(U,$J,358.3,5134,2)
 ;;=^331542
 ;;^UTILITY(U,$J,358.3,5135,0)
 ;;=626.2^^47^358^38
 ;;^UTILITY(U,$J,358.3,5135,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5135,1,3,0)
 ;;=3^626.2
 ;;^UTILITY(U,$J,358.3,5135,1,4,0)
 ;;=4^Excessive Menstrauation
 ;;^UTILITY(U,$J,358.3,5135,2)
 ;;=^75895
 ;;^UTILITY(U,$J,358.3,5136,0)
 ;;=V16.41^^47^358^39
 ;;^UTILITY(U,$J,358.3,5136,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5136,1,3,0)
 ;;=3^V16.41
 ;;^UTILITY(U,$J,358.3,5136,1,4,0)
 ;;=4^Fam HX, Malig Neopl of Ovary
 ;;^UTILITY(U,$J,358.3,5136,2)
 ;;=^317951
 ;;^UTILITY(U,$J,358.3,5137,0)
 ;;=625.6^^47^358^40
 ;;^UTILITY(U,$J,358.3,5137,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5137,1,3,0)
 ;;=3^625.6
 ;;^UTILITY(U,$J,358.3,5137,1,4,0)
 ;;=4^Fem Stress Incontinence
 ;;^UTILITY(U,$J,358.3,5137,2)
 ;;=^114717
 ;;^UTILITY(U,$J,358.3,5138,0)
 ;;=V53.99^^47^358^43
 ;;^UTILITY(U,$J,358.3,5138,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5138,1,3,0)
 ;;=3^V53.99
 ;;^UTILITY(U,$J,358.3,5138,1,4,0)
 ;;=4^Fit/Adjust Device NEC
 ;;^UTILITY(U,$J,358.3,5138,2)
 ;;=^329974
 ;;^UTILITY(U,$J,358.3,5139,0)
 ;;=611.71^^47^358^53
 ;;^UTILITY(U,$J,358.3,5139,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5139,1,3,0)
 ;;=3^611.71
 ;;^UTILITY(U,$J,358.3,5139,1,4,0)
 ;;=4^Mastodynia
